Through conceptualization, formulation and implementation of tailored solutions for process improvement, we empower scientists and entrepreneurs to tackle their clinical development needs and meet scientific and regulatory requirements, in a streamlined approval process.


Pets are considered a natural model for a myriad of human diseases. Clinical studies focusing on pets strongly underpin the efficacy of new products destined for humans, especially when it comes to cancer treatment.


Cancer is a frequent spontaneous disease in the pet population, sharing many similarities with human malignancies such as histological features, tumor growth over long periods of time, similar immune system response, development of tumor resistance, recurrence and metastatic lesions.

The Translation Research platform connects new discoveries to patients, and takes basic scientific research to the next level.


Explore our featured services

Find the solution that fits your company

Step 1

Designing and performing clinical studies on pets that are considered a natural model for certain human diseases.


Data from these studies is used to support the efficacy of new products destined for the human and veterinary markets.

Our ability to conduct pilot studies and small clinical trials allows us to generate preliminary data on your compound, and analyze its impact on the veterinary market.

Step 2

With promising preliminary data, Ridge Research will assist your company in obtaining the financial support needed to complete the study and registration process.

Step 3

We will help you launch your product in targeted global markets, with a higher return of investment, allowing your company to benefit from revenue from the veterinary markets while human clinical trials are being performed.